Caxton Associates LP Clearside Biomedical, Inc. Transaction History

Caxton Associates LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.35 - $2.88 $48,486 - $103,438	-35,916 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$2.72 - $5.72 $83,376 - $175,335	-30,653 Reduced 46.05%	35,916 $99,000
Q3 2021 Nov 15, 2021	BUY	$4.83 - $7.2 $202,338 - $301,622	41,892 Added 169.76%	66,569 $399,000
Q2 2021 Aug 16, 2021	BUY	$2.32 - $5.38 $57,250 - $132,762	24,677 New	24,677 $120,000

13.4M

17.6K

100

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $61.4M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

Stay updated on Caxton Associates LP with notifications on news.